Home

 >

Locations

>

 Plant - Aurangabad

Plant - Aurangabad, Maharashtra state, India

  • Conforms to WHO standards

  • Manufactures oral and injectable finished dosages

  • Approval from MCC, South Africa

  • Main products: rifampicin, pyrazinamide, ethambutol and lisinopril

 Major products

Product

Therapeutic area

API

Finished dosage  

Oral

Injectable

Rifampicin

Anti-TB

 

Ethambutol

Anti-TB

 

Rifampicin +
Isoniazid

Anti-TB

 

Anti-TB
combi pack

Anti-TB

 
 
   
 

 
 © Lupin Ltd.